- Filed
- Nov 20, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Nov 20, 2023 | 30.01M sh |
| Cash And Equivalents | Q1 2024 · Sep 30, 2023 | $729.83K |
| Stockholders Equity | Q1 2024 · Sep 30, 2023 | −$258.96K |
| Stockholders Equity | Q1 2024 · Jun 30, 2023 | −$541.96K |
| Current Liabilities | Q1 2024 · Sep 30, 2023 | $1.57M |
| Current Liabilities | Q1 2024 · Jun 30, 2023 | $2.05M |
| Total Liabilities | Q1 2024 · Sep 30, 2023 | $1.57M |
| Total Liabilities | Q1 2024 · Jun 30, 2023 | $2.05M |
| Current Assets | Q1 2024 · Sep 30, 2023 | $1.14M |
| Current Assets | Q1 2024 · Jun 30, 2023 | $1.31M |
| Total Assets | Q1 2024 · Sep 30, 2023 | $1.3M |
| Total Assets | Q1 2024 · Jun 30, 2023 | $1.48M |
| Revenue | Q1 2024 · Sep 30, 2023 | $1.59M |
| Revenue | Q1 2024 · Sep 30, 2022 | $415.56K |
| Shares Diluted restated | Q1 2024 · Sep 30, 2022 | 30M sh |
| Capex | Q1 2024 · Sep 30, 2022 | $49.45K |
| Operating Cash Flow | Q1 2024 · Sep 30, 2022 | $141.17K |
| Eps Diluted restated | Q1 2024 · Sep 30, 2022 | −$0.01 |
| Eps Basic restated | Q1 2024 · Sep 30, 2022 | −$0.01 |
| Sga Expense | Q1 2024 · Sep 30, 2022 | $575.53K |
| Net Income restated | Q1 2024 · Sep 30, 2022 | −$280.65K |
| Operating Income | Q1 2024 · Sep 30, 2022 | −$315.43K |
| Gross Profit | Q1 2024 · Sep 30, 2022 | $260.1K |
| Cost Of Revenue | Q1 2024 · Sep 30, 2022 | $155.46K |